Alexa Anais Plevyak, - Medicare Physical Medicine & Rehabilitation in Clarks Summit, PA

Alexa Anais Plevyak, is a medicare enrolled "Physical Medicine & Rehabilitation" physician in Clarks Summit, Pennsylvania. Her current practice location is 1157 Lackawanna Trl, Clarks Summit, Pennsylvania. You can reach out to her office (for appointments etc.) via phone at (570) 586-7764.

Alexa Anais Plevyak is licensed to practice in Pennsylvania (license number PT026674) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1457854580.

Contact Information

Alexa Anais Plevyak,
1157 Lackawanna Trl,
Clarks Summit, PA 18411-9260
(570) 586-7764
Not Available



Physician's Profile

Full NameAlexa Anais Plevyak
GenderFemale
SpecialityPhysical Medicine & Rehabilitation
Location1157 Lackawanna Trl, Clarks Summit, Pennsylvania
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1457854580
  • Provider Enumeration Date: 03/15/2018
  • Last Update Date: 03/15/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 7012366453
  • Enrollment ID: I20231212000328

Medical Identifiers

Medical identifiers for Alexa Anais Plevyak such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1457854580NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208100000XPhysical Medicine & Rehabilitation PT026674 (Pennsylvania)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Alexa Anais Plevyak allows following entities to bill medicare on her behalf.
Entity NameAlycam Inc
Entity TypePart B Supplier - Physical/occupational Therapy Group In Private Practice
Entity IdentifiersNPI Number: 1861578460
PECOS PAC ID: 9032568886
Enrollment ID: O20231206000313

News Archive

Spectrum initiates ZEVALIN and MGd Phase 2 combination study in NHL

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.

Researchers reveal how stress conditions favor lytic reactivation of herpesviruses

Hiding their DNA genome inside the nucleus of the infected cells, the herpesviruses establish a lifelong infection in humans. Not well defined stress conditions are known to wake up these parasites from their dormancy - the latent phase - and reactivate the production of new viral progeny, eventually causing cell death by lysis - the lytic phase.

Research into "insulating" brain cells could help to cure neurodegenerative diseases such as ALS

Johns Hopkins researchers say they have discovered that the central nervous system's oligodendroglia cells, long believed to simply insulate nerves as they "fire" signals, are unexpectedly also vital to the survival of neurons. Damage to these insulators appears to contribute to brain injury in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease for the Yankee baseball great who died from the disease.

DUHS chooses M*Modal's Speech Understanding technology

M*Modal, a leading provider of clinical documentation services and Speech Understanding technologies, today announced that Duke University Health System (DUHS) has selected the Company's cloud-based Speech Understanding technology to support the rollout of its Epic electronic health record.

Percentage of pregnant women living with HIV in South Africa increases, survey suggests

The percentage of pregnant women living with HIV in South Africa "has inched up to 30.2 percent from 29.4 percent last year," according to the annual National Antenatal Sentinel HIV and Syphilis Prevalence survey released by Health Minister Aaron Motsoaledi in Pretoria on Tuesday, Agence France-Presse reports.

Read more Medical News

› Verified 6 days ago

Entity NameDylan Rc Enterprises Inc
Entity TypePart B Supplier - Physical/occupational Therapy Group In Private Practice
Entity IdentifiersNPI Number: 1679165559
PECOS PAC ID: 7315396231
Enrollment ID: O20231218000756

News Archive

Spectrum initiates ZEVALIN and MGd Phase 2 combination study in NHL

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.

Researchers reveal how stress conditions favor lytic reactivation of herpesviruses

Hiding their DNA genome inside the nucleus of the infected cells, the herpesviruses establish a lifelong infection in humans. Not well defined stress conditions are known to wake up these parasites from their dormancy - the latent phase - and reactivate the production of new viral progeny, eventually causing cell death by lysis - the lytic phase.

Research into "insulating" brain cells could help to cure neurodegenerative diseases such as ALS

Johns Hopkins researchers say they have discovered that the central nervous system's oligodendroglia cells, long believed to simply insulate nerves as they "fire" signals, are unexpectedly also vital to the survival of neurons. Damage to these insulators appears to contribute to brain injury in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease for the Yankee baseball great who died from the disease.

DUHS chooses M*Modal's Speech Understanding technology

M*Modal, a leading provider of clinical documentation services and Speech Understanding technologies, today announced that Duke University Health System (DUHS) has selected the Company's cloud-based Speech Understanding technology to support the rollout of its Epic electronic health record.

Percentage of pregnant women living with HIV in South Africa increases, survey suggests

The percentage of pregnant women living with HIV in South Africa "has inched up to 30.2 percent from 29.4 percent last year," according to the annual National Antenatal Sentinel HIV and Syphilis Prevalence survey released by Health Minister Aaron Motsoaledi in Pretoria on Tuesday, Agence France-Presse reports.

Read more Medical News

› Verified 6 days ago

Entity NameDerek Enterprises Llc
Entity TypePart B Supplier - Physical/occupational Therapy Group In Private Practice
Entity IdentifiersNPI Number: 1659457158
PECOS PAC ID: 1355791252
Enrollment ID: O20231219000023

News Archive

Spectrum initiates ZEVALIN and MGd Phase 2 combination study in NHL

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.

Researchers reveal how stress conditions favor lytic reactivation of herpesviruses

Hiding their DNA genome inside the nucleus of the infected cells, the herpesviruses establish a lifelong infection in humans. Not well defined stress conditions are known to wake up these parasites from their dormancy - the latent phase - and reactivate the production of new viral progeny, eventually causing cell death by lysis - the lytic phase.

Research into "insulating" brain cells could help to cure neurodegenerative diseases such as ALS

Johns Hopkins researchers say they have discovered that the central nervous system's oligodendroglia cells, long believed to simply insulate nerves as they "fire" signals, are unexpectedly also vital to the survival of neurons. Damage to these insulators appears to contribute to brain injury in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease for the Yankee baseball great who died from the disease.

DUHS chooses M*Modal's Speech Understanding technology

M*Modal, a leading provider of clinical documentation services and Speech Understanding technologies, today announced that Duke University Health System (DUHS) has selected the Company's cloud-based Speech Understanding technology to support the rollout of its Epic electronic health record.

Percentage of pregnant women living with HIV in South Africa increases, survey suggests

The percentage of pregnant women living with HIV in South Africa "has inched up to 30.2 percent from 29.4 percent last year," according to the annual National Antenatal Sentinel HIV and Syphilis Prevalence survey released by Health Minister Aaron Motsoaledi in Pretoria on Tuesday, Agence France-Presse reports.

Read more Medical News

› Verified 6 days ago

Entity NameSteffie Enterprises, Inc
Entity TypePart B Supplier - Physical/occupational Therapy Group In Private Practice
Entity IdentifiersNPI Number: 1184700684
PECOS PAC ID: 0840225736
Enrollment ID: O20240119000010

News Archive

Spectrum initiates ZEVALIN and MGd Phase 2 combination study in NHL

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.

Researchers reveal how stress conditions favor lytic reactivation of herpesviruses

Hiding their DNA genome inside the nucleus of the infected cells, the herpesviruses establish a lifelong infection in humans. Not well defined stress conditions are known to wake up these parasites from their dormancy - the latent phase - and reactivate the production of new viral progeny, eventually causing cell death by lysis - the lytic phase.

Research into "insulating" brain cells could help to cure neurodegenerative diseases such as ALS

Johns Hopkins researchers say they have discovered that the central nervous system's oligodendroglia cells, long believed to simply insulate nerves as they "fire" signals, are unexpectedly also vital to the survival of neurons. Damage to these insulators appears to contribute to brain injury in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease for the Yankee baseball great who died from the disease.

DUHS chooses M*Modal's Speech Understanding technology

M*Modal, a leading provider of clinical documentation services and Speech Understanding technologies, today announced that Duke University Health System (DUHS) has selected the Company's cloud-based Speech Understanding technology to support the rollout of its Epic electronic health record.

Percentage of pregnant women living with HIV in South Africa increases, survey suggests

The percentage of pregnant women living with HIV in South Africa "has inched up to 30.2 percent from 29.4 percent last year," according to the annual National Antenatal Sentinel HIV and Syphilis Prevalence survey released by Health Minister Aaron Motsoaledi in Pretoria on Tuesday, Agence France-Presse reports.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Alexa Anais Plevyak is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Alexa Anais Plevyak,
913 Oakwood Dr,
South Abington Township, PA 18411-9725

Ph: () -
Alexa Anais Plevyak,
1157 Lackawanna Trl,
Clarks Summit, PA 18411-9260

Ph: (570) 586-7764

News Archive

Spectrum initiates ZEVALIN and MGd Phase 2 combination study in NHL

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN (ibritumomab tiuxetan) Injection for intravenous use + rituximab in combination with motexafin gadolinium (MGd) in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.

Researchers reveal how stress conditions favor lytic reactivation of herpesviruses

Hiding their DNA genome inside the nucleus of the infected cells, the herpesviruses establish a lifelong infection in humans. Not well defined stress conditions are known to wake up these parasites from their dormancy - the latent phase - and reactivate the production of new viral progeny, eventually causing cell death by lysis - the lytic phase.

Research into "insulating" brain cells could help to cure neurodegenerative diseases such as ALS

Johns Hopkins researchers say they have discovered that the central nervous system's oligodendroglia cells, long believed to simply insulate nerves as they "fire" signals, are unexpectedly also vital to the survival of neurons. Damage to these insulators appears to contribute to brain injury in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease for the Yankee baseball great who died from the disease.

DUHS chooses M*Modal's Speech Understanding technology

M*Modal, a leading provider of clinical documentation services and Speech Understanding technologies, today announced that Duke University Health System (DUHS) has selected the Company's cloud-based Speech Understanding technology to support the rollout of its Epic electronic health record.

Percentage of pregnant women living with HIV in South Africa increases, survey suggests

The percentage of pregnant women living with HIV in South Africa "has inched up to 30.2 percent from 29.4 percent last year," according to the annual National Antenatal Sentinel HIV and Syphilis Prevalence survey released by Health Minister Aaron Motsoaledi in Pretoria on Tuesday, Agence France-Presse reports.

Read more News

› Verified 6 days ago


Physical Medicine & Rehabilitation Doctors in Clarks Summit, PA


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.